金石亚药(300434) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 reached ¥234,715,731.62, representing a 21.40% increase compared to the same period last year[2] - Net profit attributable to shareholders was ¥18,926,849.28, a significant increase of 211.68% year-on-year[2] - The net profit after deducting non-recurring gains and losses was ¥15,005,022.22, up 184.20% from the previous year[2] - Total operating revenue for Q3 2024 was CNY 756,645,811.15, a decrease of 8.5% compared to CNY 827,063,956.04 in Q3 2023[13] - The net profit for Q3 2024 was CNY 55,880,555.94, a decrease of 58.8% compared to CNY 135,495,906.37 in Q3 2023[14] - Operating profit for the quarter was CNY 89,032,917.43, a decline of 48.0% from CNY 171,625,782.06 in the same period last year[14] - The total profit for the quarter was CNY 82,697,515.64, a decrease of 51.9% from CNY 171,830,475.49 in the same quarter last year[14] Assets and Liabilities - Total assets at the end of Q3 2024 were ¥2,834,722,341.46, down 8.60% from the end of the previous year[2] - The company's total assets decreased to CNY 2,834,722,341.46 from CNY 3,101,438,665.01, a decline of about 8.6%[12] - Current liabilities totaled CNY 328,672,372.05, down significantly from CNY 601,171,878.83, indicating a reduction of approximately 45%[12] - Non-current liabilities decreased to CNY 69,195,210.57 from CNY 76,200,757.36, a decline of about 9.3%[12] - The company's total equity increased to CNY 2,436,854,758.84 from CNY 2,424,066,028.82, reflecting a growth of approximately 0.5%[12] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥71,394,399.48, a decrease of 10.65% compared to the same period last year[5] - The net cash flow from operating activities was 71,394,399.48, a decrease from 79,904,989.91 in the previous period, indicating a decline of approximately 6.3%[17] - The total cash outflow from investing activities was 244,194,515.72, significantly higher than 33,873,973.94 in the previous period, reflecting an increase of over 620%[17] - The net cash flow from financing activities was -49,979,024.03, compared to -470,812.35 in the previous period, showing a substantial increase in cash outflow[17] - The total cash and cash equivalents at the end of the period were 357,383,549.09, down from 511,952,047.47, representing a decrease of approximately 30%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 18,678[7] - The largest shareholder, Gao Yaping, holds 25.11% of the shares, totaling 100,878,929 shares[7] - The company has a significant number of shares held by major shareholders, with the top three shareholders holding a combined total of 93.34%[7] - The company reported a total of 66,961,406 restricted shares at the beginning of the period, with 7,338,620 shares released during the period, leaving 59,622,786 restricted shares at the end[9] Operational Highlights - The company is focusing on expanding its production facilities, as indicated by a significant increase of 10,881.85% in construction in progress[5] - The company plans to continue its market expansion and product development strategies in the upcoming quarters[9] Revenue and Expenses - Total operating costs increased to CNY 670,119,991.15, up from CNY 651,362,855.09, reflecting a rise of approximately 2.5%[13] - Sales expenses increased to CNY 172,290,852.34, up 9.0% from CNY 156,857,766.57 in Q3 2023[14] - Research and development expenses decreased to CNY 30,034,741.20, down 25% from CNY 40,018,123.05 in the previous year[14] Investment and Receivables - The company’s trading financial assets increased significantly from 42,358,661.00 CNY to 174,087,628.76 CNY during the reporting period[10] - Accounts receivable rose from 79,477,350.02 CNY to 97,124,214.67 CNY, indicating a growth of approximately 22.5%[10] - The company’s financing receivables decreased from 296,290,232.19 CNY to 131,272,536.64 CNY, a decline of about 55.7%[10] - Other receivables decreased from 24,473,816.03 CNY to 21,245,512.18 CNY, a reduction of approximately 13.3%[10]